Role of cholinesterase inhibitors in dementia care needs rethinking
- PMID: 16946340
- PMCID: PMC1557932
- DOI: 10.1136/bmj.38945.478160.94
Role of cholinesterase inhibitors in dementia care needs rethinking
Abstract
The NHS focus on memory clinics driven by drugs that slow cognitive decline is taking resources away from services offering long term integrated care. The role of these clinics needs reconsideration alongside availability of the drugs
Figures
Comment in
-
Role of cholinesterase inhibitors in dementia care: memory clinics and cholinesterase inhibitors have their place.BMJ. 2006 Sep 16;333(7568):602. doi: 10.1136/bmj.333.7568.602-b. BMJ. 2006. PMID: 16974022 Free PMC article. No abstract available.
-
Role of cholinesterase inhibitors in dementia care: NICE's economic analysis has limitations.BMJ. 2006 Sep 16;333(7568):603. doi: 10.1136/bmj.333.7568.603. BMJ. 2006. PMID: 16974027 Free PMC article. No abstract available.
References
-
- National Institute for Clinical Excellence. Technology appraisal guidance number 19. Donepezil, rivastigmine and galantamine for the treatment of Alzheimer's disease. London: NICE, 2001.
-
- Clegg A, Bryant J, Nicholson T, McIntyre L, De Broe S, Gerard K, et al. Clinical and cost effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review. Health Technol Assess 2001;5(1). 1-137. - PubMed
-
- Corey-Bloom J, Fleisher AS. The natural history of Alzheimer's disease. In: Burns A, O'Brien J, Ames D, eds. Dementia. 3rd ed. Oxford: Oxford University Press, 2005: 376-86.
-
- Neumann PJ, Kuntz KM, Leon J, Araki SS, Hermann RC, Hsu MA, et al. Health utilities in Alzheimer's disease: a cross-sectional study of patients and caregivers. Med Care 1999;37: 27-32. - PubMed
-
- Yeo G, Gallagher-Thompson D, eds. Ethnicity and the dementias. Washington, DC: Taylor and Francis, 1996.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical